Jump to navigation
WITH ASSAYS THAT ANALYZE INVASIVE
CIRCULATING TUMOR CELLS (iCTC’S)
IN STANDARD PATIENT BLOOD SAMPLES.
Our Proprietary Cell Adhesion Matrix technology enables isolation of true metastasis-initiating tumor cells.
Vitatex assays may benefit patients by early detection of aggressive disease, selection of the right drug and monitoring treatment.
Companies developing new cancer drugs can access new models of metastasis and assay services that improve patient selection and monitoring in clinical trials.